Skip to search formSkip to main contentSkip to account menu

AF-219

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
ABSTRACT Introduction: Purinergic P2X3-P2X2/3 receptors are placed in nociceptive neurons’ strategic location and show unique… 
Highly Cited
2018
Highly Cited
2018
Significance Allosteric regulation, produced by the binding of a ligand at an allosteric site topographically distinct from the… 
Review
2017
Review
2017
Chronic lung diseases such as asthma, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis are a major and… 
2017
2017
Introduction: MK-7264 (formerly AF-219) is a P2X3 receptor antagonist that has been shown to reduce cough frequency in patients… 
2016
2016
Introduction and objectives Effective therapies for chronic cough are a significant unmet need. Recently a P2X3 antagonist (AF… 
Review
2015
Review
2015
  • D. SpinaC. Page
  • 2015
  • Corpus ID: 206974564
Review
2014
Review
2014
Abstract:Treatments for inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), functional dyspepsia, or motility… 
2013
2013
P2X3 receptors are ATP‐gated channels with expression somewhat limited to primary afferent populations suspected of chronic… 
2013
2013
Background Pre-clinical studies suggest that P2X3 receptors are expressed by airway vagal afferents and contribute to the… 
2013
2013
The P2X3 antagonist AF‐219, being studied in bladder disorders, is eliminated by renal clearance. Local renal delivery of AF‐219…